Generate Biomedicines annual revenue
2024
2025
Generate Biomedicines Revenue Growth & History (GENB)
Generate Biomedicines reported $31.9M in revenue for fiscal 2025, an increase of 55.89% from the previous fiscal year.
View full Generate Biomedicines company overviewGenerate Biomedicines annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $31.9M | $11.4M | +55.89% |
| 2024 | 2024-12-31 | $20.5M | — | — |
Generate Biomedicines quarterly revenue
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.3M | −$3.8M | −37.67% |
| Q1 2026 | 2026-03-31 | $7.2M | −$1.6M | −18.08% |
| Q2 2025 | 2025-06-30 | $10.1M | — | — |
| Q1 2025 | 2025-03-31 | $8.8M | — | — |
Generate Biomedicines revenue growth trends
Generate Biomedicines's latest reported quarter, Q2 2026, generated $6.3M in revenue, a decrease of 37.67% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Generate Biomedicines source filings ↗